T 0122/25 of 19.03.2026
- European Case Law Identifier
- ECLI:EP:BA:2026:T012225.20260319
- Date of decision
- 19 March 2026
- Case number
- T 0122/25
- Online on
- 7 May 2026
- Petition for review of
- -
- Application number
- 13700569.0
- IPC class
- A61M 5/315A61M 5/31
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- INJECTION DEVICE WITH A SLIDING SCALE
- Applicant name
- Novo Nordisk A/S
- Opponent name
- 1. Sanofi-Aventis Deutschland GmbH
2. medmix Switzerland AG - Board
- 3.2.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 83European Patent Convention Art 84European Patent Convention Art 56
- Keywords
- Amendments - extension beyond the content of the application as filed (no)
Sufficiency of disclosure - main request (yes)
Sufficiency of disclosure - undue burden (no)
Claims - clarity
Claims - main request (yes)
Claims - lack of clarity no ground for opposition
Claims - essential features
Claims - conciseness (yes)
Claims - functional features (yes)
Inventive step - main request (yes)
Inventive step - could-would approach - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form on the basis of the following documents:
Claims: Claims 1 to 7 of the main request filed with the statement of grounds of appeal of the patent proprietor.
Description: The patent specification with the amended paragraphs [0016] and [0031] filed with the patent proprietor's letter of 25 July 2025.
Drawings: of the patent specification.